F-group (family)
7579.1.1.10 Thioesterase
Ligands and drugs
329
Member domains
84
with ligand contacts (≤ 4 Å)
25.5% of members
73
with DrugDomain annotations
22.2% of members
42
with a DrugBank compound
12.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7579.1.1.10 belongs to X-group 7579 alpha/beta-Hydrolases, which binds 10.2 ligand superclasses per 20 proteins, broader than 97% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03345 | BME | Mercaptoethanol | 2 |
| DB04447 | DTT | 1,4-Dithiothreitol | 2 |
| DB07703 | E4H | (3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE | 2 |
| DB08431 | PSK | [(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID | 2 |
| DB01034 | — | Cerulenin | 1 |
| DB01083 | — | — | 1 |
| DB03297 | PMS | Benzylsulfonic acid | 1 |
| DB08759 | YML | [(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 8 |
| E9H | hexadecyl dihydrogen phosphate | 8 |
| CL | CHLORIDE ION | 5 |
| MGmetal | MAGNESIUM ION | 4 |
| MUY | (R)-[(S)-[(3S)-3-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoazetidin-1-yl](4-hydroxyphenyl)methyl]methylphosphinic acid | 4 |
| 2Q5 | (2R)-2-{[(2R)-2-{[(2S)-2-{[(2R)-2-hydroxypropyl]oxy}propyl]oxy}propyl]oxy}propan-1-ol | 3 |
| 5V8 | 2-(4-hydroxyphenyl)-~{N}-methyl-5-oxidanyl-4-(piperidin-1-ylmethyl)-1-benzofuran-3-carboxamide | 2 |
| 7IJ | 3,8-bis(oxidanyl)-7-(piperidin-1-ylmethyl)-[1]benzofuro[3,2-c]chromen-6-one | 2 |
| A1AWE | 2-{[(1R)-1-(6-nitro-2H-1,3-benzodioxol-5-yl)ethyl]sulfanyl}ethyl formate | 2 |
| A1AWF | (2S,4R,5S,6S,8R,12R,13R)-5,13-dihydroxy-2,4,6,8,12-pentamethyl-3,9-dioxopentadecanal | 2 |
| BME | BETA-MERCAPTOETHANOL | 2 |
| DH9 | (2S,3S,5S)-5-[(N-FORMYL-L-LEUCYL)OXY]-2-HEXYL-3-HYDROXYHEXADECANOIC ACID | 2 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 2 |
| E4H | (3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE | 2 |
| I28 | ethyl 5-hydroxy-4-[(4-methylpiperidin-1-yl)methyl]-2-phenyl-1-benzofuran-3-carboxylate | 2 |
| I66 | ethyl 5-hydroxy-2-phenyl-4-(pyrrolidin-1-ylmethyl)-1-benzofuran-3-carboxylate | 2 |
| IJJ | 3-(3,4-dimethoxyphenyl)-~{N}-[2-(3,4-dimethoxyphenyl)ethyl]-1,2,4-oxadiazole-5-carboxamide | 2 |
| IKG | ~{N}-[(1~{R})-2-[4-(azetidin-1-ylcarbonyl)phenyl]-1-cyano-ethyl]-3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazole-5-carboxamide | 2 |
| IL8 | ~{N}-[2-[4-(azetidin-1-ylcarbonyl)phenyl]ethyl]-3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazole-5-carboxamide | 2 |
| JS1 | ethyl 4-[(dimethylamino)methyl]-5-hydroxy-2-phenyl-1-benzofuran-3-carboxylate | 2 |